Palladium(II)-catalyzed enantioselective aerobic dialkoxylation of 2-propenyl phenols: A pronounced effect of copper additives on enantioselectivity

Journal of the American Chemical Society

Volumn 129, Issue 11, 2007, Pages 3076-3077

  Zhang, Yang ^a   Sigman, Matthew S ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPENYLPHENOL; COPPER; LIGAND; OXAZOLINE DERIVATIVE; PALLADIUM; PHENOL DERIVATIVE; QUINOLINE DERIVATIVE; QUINONE DERIVATIVE; SPARTEINE; STYRENE; UNCLASSIFIED DRUG;

ARTICLE; ASYMMETRIC CATALYSIS; CATALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; ENANTIOSELECTIVITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

CATALYSIS; COPPER; LIGANDS; MOLECULAR CONFORMATION; OXIDATION-REDUCTION; PALLADIUM; PHENOLS; STEREOISOMERISM; SUBSTRATE SPECIFICITY;

EID: 33947407602     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja070263u     Document Type: Article

References (18)

1. For reviews, see: (a) Tietze, L. F.; Ila, H.; Bell, H. P. Chem. Rev. 2004, 104, 3453-3516.
2. (b) Palladium Reagents and Catalysis; Tsuji, J., Ed.; Wiley: Chichester, U.K., 1995.
3. For examples of intermolecular enantioselective nucleopalladation, see: (a) El-Qisairi, A. K.; Qaseer, H. A.; Henry, P. M. J. Organomet. Chem. 2002, 656, 168-176.
4. (b) Itami, K.; Palmgren, A.; Thorarensen, A.; Bäckvall, J.-E. J. Org. Chem. 1998, 63, 6466-6471.
5. For recent intramolecular examples, see: (c) Yip, K.-T.; Yang, M.; Law, K.-L.; Zhu, N.-Y.; Yang, D. J. Am. Chem. Soc. 2006, 128, 3130-3131.
6. (d) Trend, R. M.; Ramtohul, Y. K.; Stoltz, B. M. J. Am. Chem. Soc. 2005, 127, 17778-17788.
7. (e) Uozumi, Y.; Kato, K.; Hayashi, T. J. Am. Chem. Soc. 1997, 119, 5063-5064.
8. (a) Schultz, M. J.; Sigman, M. S. J. Am. Chem. Soc. 2006, 128, 1460-1461.
9. For a related example, see: Chevrin, C.; Bras, J. L.; Hénin, F.; Muzart, J. Synthesis 2005, 2615-2618.
10. (a) Bols, M.; Binderup, L.; Hansen, J.; Rasmussen, P. Carbohydr. Res. 1992, 235, 141-149.
11. (b) Tanaka, Y.; Graefe, U.; Yazawa, K.; Mikami, Y. J. Antibiot. 1998, 51, 589-591.
12. (c) Takenaka, M.; Watanabe, T.; Sugahara, K.; Harada, Y.; Yoshida, S.; Sugawara, F. Biosci., Biotechnol., Biochem. 1997, 61, 1440-1444.
13. (d) Huang, L.; Kashiwada, Y.; Cosentino, L. M.; Fan, S.; Chen, C.-H.; McPhail, A. T.; Fujioka, T.; Mihashi, K.; Lee, K.-H. J. Med. Chem. 1994, 37, 3947-3955.
14. Catalyst decomposition was observed.
15. For recent enantioselective reactions utilizing chiral quinoline oxazolines, see: (a) Abrunhosa, I.; Bioton, L.; Gaumount, A.; Gulea, M.; Masson, S. Tetrahedron 2004, 60, 9263.
16. (b) Chelucci, G.; Sanna, M.; Gladiali, S. Tetrahedron 2000, 56, 2889.
17. For a recent review of oxazoline synthetic methods, see: Desimoni, G.; Faita, G.; Jorgensen, K. A. Chem. Rev. 2006, 106, 3561-3651.
18. The absolute configuration of the product was determined by comparison to an independently prepared authentic sample. See Supporting Information for details.